These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8085276)

  • 21. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
    Testa R; Caglieris S; Risso D; Arzani L; Campo N; Alvarez S; Giannini E; Lantieri PB; Celle G
    Am J Gastroenterol; 1997 Dec; 92(12):2268-73. PubMed ID: 9399768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of dynamic and morphological studies in the assessment of potential liver donors.
    Karayalçin K; Mirza DF; Harrison RF; Da Silva RF; Hubscher SG; Mayer AD; Buckels JA; McMaster P
    Transplantation; 1994 May; 57(9):1323-7. PubMed ID: 8184469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical importance of conventional and quantitative liver function tests in liver transplantation.
    Tanaka E; Inomata S; Yasuhara H
    J Clin Pharm Ther; 2000 Dec; 25(6):411-9. PubMed ID: 11123494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection.
    Lorf T; Schnitzbauer AA; Schaefers SK; Scherer MN; Schlitt HJ; Oellerich M; Becker H; Obed A
    Hepatogastroenterology; 2008; 55(82-83):539-43. PubMed ID: 18613404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide.
    McKindley DS; Boulet J; Sachdeva K; Wang P; Chichester C
    Shock; 2002 Mar; 17(3):199-204. PubMed ID: 11900338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
    Chen Y; Potter JM
    Clin Chem; 1992 Dec; 38(12):2426-30. PubMed ID: 1458579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of serial determination of MEGX and hyaluronic acid early after orthotopic liver transplantation.
    Schütz E; Luy-Kaltefleiter M; Kaltefleiter M; Burdelski M; Ringe B; Armstrong VW; Oellerich M
    Eur J Clin Invest; 1996 Oct; 26(10):907-16. PubMed ID: 8911865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
    Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of age on plasma MEGX concentrations.
    Orlando R; Palatini P
    Br J Clin Pharmacol; 1997 Aug; 44(2):206-8. PubMed ID: 9278213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection criteria for liver transplant donors.
    Schroeder TJ; Pesce AJ; Ryckman FC; Tressler TP; Brunson ME; Pedersen SH; Tchervenkov JI; Penn I; Alexander JW; Balistreri WF
    J Clin Lab Anal; 1991; 5(4):275-7. PubMed ID: 1890541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of liver disease and food on plasma MEGX concentrations.
    Pritchard-Davies R; Gross AS; Shenfield GM
    Br J Clin Pharmacol; 1994 Mar; 37(3):298-301. PubMed ID: 8198941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The validity of the MEGX test in correlation with histology after orthotopic rat liver transplantation.
    Keck H; Bachmann S; Knoop M; Dobis C; Meyer A; Neuhaus P
    Transpl Int; 1994; 7 Suppl 1():S208-12. PubMed ID: 11271204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic function as assessed by lidocaine metabolism in sickle cell disease.
    Gremse DA; Fillingim E; Hoff CJ; Wells DJ; Boerth RC
    J Pediatr; 1998 Jun; 132(6):989-93. PubMed ID: 9627591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The monoethylglycinexylidide test is more useful for evaluating liver function than indocyanine green test: case of a patient with remarkably decreased indocyanine green half-life.
    Oda Y; Kariya N; Nakamoto T; Nishi S; Asada A; Fujimori M
    Ther Drug Monit; 1995 Apr; 17(2):207-10. PubMed ID: 7624913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.